Replies to post #116184 on Biotech Values

[dewophile]

for HIV they need lifelong therapy - if HIV could be cured in 6 months i bet you wouldn't need a third agent for added protection against resistance
but let me say in general i agree with you re 3 agents - certainly a better chance, i was just saying IF any drugs had a chance in HCV it would be these high barrier to resistance agents

[oc631]

Although the viruses themselves are very different, it’s worth noting that Truvada is almost never used by itself in HIV. Truvada is conceptually similar to VRUS’ 2-drug HCV combo insofar as it consists of a purine nuke and a pyrimidine nuke with non-overlapping barriers to resistance.

You fail to mention that Truvada was the SOC in HIV before the release of Atripla.